Strategies Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Strategies Wealth Advisors's PFE Position: Q1 2026 in Review
Strategies Wealth Advisors reduced its Pfizer (PFE) stake by 4.1% in Q1 2026, selling an estimated $10.7K and leaving 9,462 shares worth $266K. The position accounts for 0.03% of the portfolio, ranked #151.
Strategies Wealth Advisors first reported a position in PFE in Q1 2025 and has held it in 5 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Strategies Wealth Advisors held 9,462 shares of Pfizer worth $266K as of Q1 2026.
- Strategies Wealth Advisors sold 402 Pfizer shares in Q1 2026, an estimated $10.7K.
- Pfizer made up 0.03% of Strategies Wealth Advisors's portfolio in Q1 2026, its #151 holding.
- Strategies Wealth Advisors first reported a position in Pfizer in Q1 2025 and has held it in 5 quarters since.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Strategies Wealth Advisors's 13F filing for Q1 2026, filed 15 May 2026.